🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or prison.

Service Response and Content Elimination

Based on TikTok, the service has removed problematic content and banned related keywords and query recommendations. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also found communities with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, positive testimonials and detailed guides for mixing or administering at home.

Within minutes of joining one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Product Details and Costs

Inside these communities, posts display black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.